(Q43901367)

English

Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer

scientific article published in February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer (English)

1 reference

Europe PubMed Central

27 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Gilbert D A Padula

1

1 reference

Europe PubMed Central

27 November 2017

Michael J Zelefsky

2

1 reference

Europe PubMed Central

27 November 2017

Ennapadam S Venkatraman

3

1 reference

Europe PubMed Central

27 November 2017

Zvi Fuks

4

1 reference

Europe PubMed Central

27 November 2017

Henry J Lee

5

1 reference

Europe PubMed Central

27 November 2017

Linda Natale

6

1 reference

Europe PubMed Central

27 November 2017

Steven A Leibel

7

1 reference

Europe PubMed Central

27 November 2017

language of work or name

0 references

publication date

1 February 2002

1 reference

Europe PubMed Central

27 November 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

27 November 2017

52

1 reference

Europe PubMed Central

27 November 2017

2

1 reference

Europe PubMed Central

27 November 2017

439-443

1 reference

Europe PubMed Central

27 November 2017

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902604-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902604-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902604-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant hormonal downsizing of localized carcinoma of the prostate: effects on the volume of normal tissue irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902604-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902604-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of bicalutamide versus castration in patients with advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902604-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent androgen suppression in the management of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902604-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of external beam radiotherapy on endocrine function in patients with carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902604-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Re: Time to normalization of serum testosterone after 3-month luteinizing hormone-releasing hormone agonist administered in the neoadjuvant setting: implications for dosing schedule and neoadjuvant study consideration

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902604-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Time to normalization of serum testosterone after 3-month luteinizing hormone-releasing hormone agonist administered in the neoadjuvant setting: implications for dosing schedule and neoadjuvant study consideration

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902604-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of external radiation therapy for cancer of the prostate on the serum concentrations of testosterone, follicle-stimulating hormone, luteinizing hormone and prolactin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902604-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum testosterone levels after external beam radiation for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902604-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective analysis of time to normalization of serum testosterone after withdrawal of androgen deprivation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902604-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902604-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Partial likelihood

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902604-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902604-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(01)02604-9

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43901367&oldid=2104262259"